A newly published article — and an associated editorial — in the Annals of Internal Medicine has addressed the possible benefits of taking low-dose aspirin as a method to prevent the progression of newly diagnosed prostate cancer. … READ MORE …
Filed under: Uncategorized | Tagged: aspirin, outcome, Prevention, progression, risk | 7 Comments »
New data derived from the Physicans’ Health Study have suggested that there is an association between regular aspirin use and avoidance of risk for lethal forms of prostate cancer. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: aspirin, death, lethal, risk | 4 Comments »
The clinical research community in the UK (with access to relevant government funding) still appears to be able to do the types of trial of older drugs that would rarely if ever get done here in America today. … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: adjuvant, aspirin, curative, localized, Treatment | Leave a comment »
Data in JAMA Oncology, based on a recent analysis of results from the Nurses Health Study and the Health Professionals Follow-up Study, suggest that daily aspirin may lower risk for gastrointestinal cancers (e.g., colon and rectal cancers) but had no significant impact on risk for prostate cancer. … READ MORE …
Filed under: Prevention | Tagged: aspirin, Prevention, risk | 1 Comment »
According to media reports on the BBC’s web site and in The Guardian newspaper in the UK, a new clinical trial to be implemented by the National Health Service (NHS) will explore whether a simple aspirin regimen can be used to help to prevent the recurrence of certain types of early stage cancer following first-line treatment. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: aspirin, Prevention, recurrence, trial | Leave a comment »
An open-access, full text article in the April issue of the Journal of Urology addresses long-standing questions about the impact of regular aspirin use on the long-term outcomes of men diagnosed with and treated for prostate cancer. … READ MORE
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: anti-inflammatory, aspirin, mortality, overall, prostate cancer-specific | 2 Comments »
Your sitemaster has just been made aware of a trial that has been ongoing since 2010. However, it may have implications for determining whether regular aspirin therapy can actually lower risk for prostate cancer-specific mortality. … READ MORE …
Filed under: Living with Prostate Cancer, Prevention | Tagged: aspirin, mortality, risk | Leave a comment »
Yet again we have the presentation of data suggesting that men who take a regular dose of aspirin (or a similar anti-inflammatory agent) may have a lower overall risk for prostate cancer in general and for high-risk prostate cancer in particular … but please note the word “may” and remember that the daily use of aspirin is not free of risk for side effects — some of which can be significant. … READ MORE …
Filed under: Diagnosis, Prevention, Risk | Tagged: anti-inflammatory, aspirin, Prevention, risk | 6 Comments »
An article just published in Renal & Urology News states that “Men who take aspirin doses above 75 mg have a significantly reduced risk of death from prostate cancer … compared with men who do not take aspirin.” … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: aspirin, Diagnosis, dose, survival | 5 Comments »
A study based on the CaPSURE database, and just published in the Journal of Oncology, has again suggested that prostate cancer patients who are regular users of anticoagulant are a lower risk of prostate cancer-specific mortality than non-aspirin users. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: anticoagulant, aspirin, cancer-specific, mortality | Leave a comment »
According to a media release issued by Fox Chase Cancer Center yesterday, researchers at this institution have been able to demonstrate that “aspirin reduces the risk of cancer recurrence in some prostate cancer patients.” … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: aspirin, outcome, radiation therapy, recurrence | Leave a comment »
According to a new report in The Lancet, just published on line, a daily aspirin regimen reduces deaths due to several common cancers — including those caused by prostate cancer. … READ MORE
Filed under: Diagnosis, Prevention, Risk | Tagged: aspirin, mortality, risk | Leave a comment »
A presentation to be given next week at the upcoming annual meeting of the American Society for Radiation Oncology (ASTRO) will suggest that men initially diagnosed with localized prostate cancer and who take an anti-clotting agent are at significantly lower risk for prostate cancer-specific death at 10 years of follow-up. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: anti-clotting agent, aspirin, prostate cancer-specific mortality, risk | 2 Comments »
The idea that aspirin might be able to prevent prostate cancer is not new, but a recent paper has re-stirred the controversy about the relative risks and benefits of aspirin as a preventive agent. … READ MORE …
Filed under: Prevention | Tagged: aspirin, NSAIDs, Prevention, statin | 1 Comment »
THE "NEW" PROSTATE CANCER INFOLINK 